S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Soligenix Announces Combination Vaccine for Ricin and Anthrax Achieves Simultaneous Protection|
|Soligenix Receives Additional NIAID Funding to Advance Development of OrbeShield™ in GI ARS|
|Soligenix Announces FDA Clearance of Phase 3 Clinical Protocol of SGX301 in Cutaneous T-Cell Lymphoma|
|Soligenix Expands Pipeline with Acquisition of Phase 3-Ready Oncology Clinical Program|
|Soligenix Reports Second Quarter 2014 Financial Results, and Highlights Recent Accomplishments|
|Soligenix Announces Issuance of US Patent for ThermoVax™ Technology|
|Soligenix to Present at the 16th Annual Rodman & Renshaw Global Investment Conference in New York City|
|Soligenix Awarded NIAID Contract Valued up to $24.7 Million for the Development of Heat Stable RiVax™ Vaccine|
|Soligenix Announces Positive Survival Results with Heat Stable Ricin Toxin Vaccine|
|Soligenix Advances Development of a Heat Stable Rapidly Acting Anthrax Vaccine VeloThrax™|
Click above to view more mutual fund data and stats for sngx - Soligenix Inc.